Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Tolerability, PK and PD of APPA-1 in Healthy Subjects and Osteoarthritis Patients
NCT07429565Phase 1Completed
- Sponsor
- University of Liverpool
- Start
- Apr 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in osteoarthritis (OA) comparing APPA-1 with Placebo (2 arms). Primary endpoint: Adverse Events at 77 days. Started Apr 2018; status: completed.
02
Drugs
APPA
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07429565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07429565.